Hyogo Prefectural HarimaHimeji General Medical Center

Hyōgo 670-8560

0 studies enrolling now · 4 studies all time

What they study most

Alzheimer Disease, Atherosclerotic Cardiovascular Disease, Dyslipidemias, Familial Hypercholesterolemia, High Cholesterol, Hypercholesterolemia

Studies at this site

• Randomized Study to Evaluate the Effect of Obicetrapib on Top of Maximum Tolerated Lipid-Modifying Therapies — Completed
• Cardiovascular Outcome Study to Evaluate the Effect of Obicetrapib in Patients With Cardiovascular Disease — Running, not enrolling
• A Study to Evaluate the Safety, Tolerability, and Efficacy of Long-Term Gantenerumab Administration in Participants With Alzheimer's Disease (AD) — Stopped early
• Safety and Efficacy Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD) — Stopped early